Medtronic Recalls 60,000 Paradigm Quick-Set Infusion Sets

July 14, 2009

Paradigm Quick-Set Infusion SetMedtronic has issued a recall of specific lots of infusion sets that are for use with MiniMed Paradigm insulin pumps. These infusion sets may not work properly, resulting in a delivery of too little or too much insulin, which could result in injury or death.

Medtronic Voluntarily Recalls Specific Lots of Paradigm® Quick-Set® Infusion Sets In The United States

July 1, 2009

UPDATED URL > Click Here for information on the Medtronic Paradigm Quick Set Infusion Set Recall

FDA Classifies Medtronic Voluntary February Recall for BioGlide Ventricular Snap Shunt Catheters (Models 27782, 27708 and 27802) as Class I

March 31, 2009

CONTACT: JEFF WARREN INVESTOR RELATIONS 763-505-2696

CHUCK GROTHAUS PUBLIC RELATIONS 763-505-2614

Urgent Medtronic Neuromodulation INDURA IP Product Recall

October 2, 2008

FDA has issued a Class I Recall on Medtronic Neuromodulation INDURA IP intrathecal catheters, sutureless pump connector revision kits and intrathecal catheter pump segment revision kits.

Medtronic LogoThere are potential misconnections of the Medtronic sutureless connector (”SC”) catheters from the catheter port on the medtronic pump. These misconnections have resulted in a blockage (occlusion) between the sutureless pump connector and the catheter port on the pump and disconnection from the pump connector.

Medtronic Initiates Voluntary Field Actions for Selected Heparin-Coated Products

May 15, 2008

CONTACT: DANIEL BEACH PUBLIC RELATIONS 763-505-2603

Medical Device Litigation 101

February 25, 2008

Medical Device Litigation History and Primer

1976 through Reigel v. Medtronic

Guest post provided by Denver personal injury attorney Beth Klein

Background of the Act
The Food & Drug Administration (”FDA”) governs medical devices for use and sale in the United States. The FDA was given power over medical devices in the 1976 Medical Device Amendments to the Food, Drug, & Cosmetic Act, 21 U.S.C. section 360c et seq. (AMDA@). The purpose of the MDA was to provide reasonable assurance of safety and effectiveness for all medical devices.

Supreme Court Grants Immunity to Medical Device Manufacturers

February 21, 2008

(Editorial Content)

The Supreme Court finally gave medical device makers their one true wish – Immunity from Lawsuits. Companies that produce medical devices like breast implants and implantable defibrillators now have federal protection against lawsuits arising from deaths or injuries associated with their products as long as the product has been approved for use by the FDA.

Medtronic SynchroMed EL Implantable Infusion Pumps Recalled

February 4, 2008

In a Class 1 Recall yesterday, the U.S. Food and Drug Administration has recalled all SynchroMed El pumps with motors manufactured after September 1999.